Studies from Stanford University School of Medicine Yield New Data on Klebsiella pneumoniae (In Silico and In Vitro Studies of Gent-edta Encapsulated Niosomes: a Novel Approach To Enhance the Antibacterial Activity and Biofilm Inhibition In...).

Předmět:	KLEBSIELLA pneumoniae ANTIBACTERIAL agents BIOFILMS GRAM-negative bacteria DRUGS
Zdroj:	Drug Week; 9/22/2023, p2219-2219, 1p
Abstrakt:	Keywords: Stanford; State:California; United States; North and Central America; Antibacterials; Antibiotics; Antimicrobials; Drug Resistance; Drugs and Therapies; Enterobacteriaceae; Gammaproteobacteria; Gram-Negative Bacteria; Gram-Negative Facultatively Anaerobic Rods; Health and Medicine; Klebsiella; Klebsiella pneumoniae; Proteobacteria EN Stanford State:California United States North and Central America Antibacterials Antibiotics Antimicrobials Drug Resistance Drugs and Therapies Enterobacteriaceae Gammaproteobacteria Gram-Negative Bacteria Gram-Negative Facultatively Anaerobic Rods Health and Medicine Klebsiella Klebsiella pneumoniae Proteobacteria 2219 2219 1 09/19/23 20230922 NES 230922 2023 SEP 22 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- A new study on Gram-Negative Bacteria - Klebsiella pneumoniae is now available. The niosomes displayed a controlled drug release and storage stability of at least 60 days at 4 and 25 degrees C. GENT-EDTA/Nio performance as antimicrobial agents has been evaluated by employing agar well diffusion method, minimum bactericidal concentration (MBC), and minimum inhibitory concentration (MIC) against the Kp bacteria strains. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu